Is immune system‐related hypertension associated with ovarian hormone deficiency?. Issue 3 (20th October 2015)

• Record Type: Journal Article
• Authors: Sandberg, Kathryn; Ji, Hong; Einstein, Gillian; Au, April; Hay, Meredith
• Is Part Of: Experimental physiology. Volume 101:Issue 3(2016:Mar.)
• Page Start: 368
• Page End: 374
• Publication Date: 2015-10-20
• Subjects: Physiology, Experimental -- Periodicals; 571.0724
• DOI: 10.1113/EP085149
• Languages: English
• ISSNs: 0958-0670

Abstract

Abstract : New Findings: What is the topic of this review? This review summarizes recent data on the role of ovarian hormones and sex in inflammation‐related hypertension. What advances does it highlight? The adaptive immune system has recently been implicated in the development of hypertension in males but not in females. The role of the immune system in the development of hypertension in women and its relationship to ovarian hormone production are highlighted. The immune system is known to contribute to the development of high blood pressure in males. However, the role of the immune system in the development of high blood pressure in females and the role of ovarian hormones has only recently begun to be studied. In animal studies, both the sex of the host and the T cell are critical biological determinants of susceptibility and resistance to hypertension induced by angiotensin II. In women, natural menopause is known to result in significant changes in the expression of genes regulating the immune system. Likewise, in animal models, ovariectomy results in hypertension and an upregulation in T‐cell tumour necrosis factor‐α‐related genes. Oestrogen replacement results in decreases in inflammatory genes in the brain regions involved in blood pressure regulation. Together, these studies suggest that the response of the adaptive immune system to ovarian hormone deficiency is a significant contributor to hypertension in women. Abstract :